Data from 89bio's ENLIVEN Phase 2b Trial of Pegozafermin in
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant changes on...
Source: globenewswire.com
Page 7 - Controlled Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Controlled Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Controlled Trial Today - Breaking & Trending Today
Antioxidants to Help You When You Quit Smoking
Smoking is injurious to health, but it sure is a tough addiction to stop. Cure yourself with the power of antioxidants to eliminate health risks such as lung cancer and dental problems.
Source: medindia.net
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio
Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.
Source: yahoo.com
Relmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2023 Annual Meeting
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
Source: prnewswire.com
An Overview of the 5 Types Of Neuromodulation Devices
This article provides an overview on the five types of neuromodulation devices: spinal cord stimulation, deep brain stimulation, sacral nerve...
Source: meddeviceonline.com